Smithfield Trust Co. bought a new position in iShares Nasdaq Biotechnology ETF (NASDAQ:IBB) in the 3rd quarter, Holdings Channel.com reports. The firm bought 600 shares of the financial services provider’s stock, valued at approximately $60,000.
Other large investors also recently made changes to their positions in the company. Great Valley Advisor Group Inc. grew its position in iShares Nasdaq Biotechnology ETF by 26.4% in the second quarter. Great Valley Advisor Group Inc. now owns 2,271 shares of the financial services provider’s stock worth $248,000 after acquiring an additional 475 shares in the last quarter. Cetera Advisor Networks LLC lifted its stake in iShares Nasdaq Biotechnology ETF by 0.3% in the second quarter. Cetera Advisor Networks LLC now owns 57,742 shares of the financial services provider’s stock worth $6,301,000 after purchasing an additional 199 shares during the last quarter. Bangor Savings Bank bought a new stake in iShares Nasdaq Biotechnology ETF in the second quarter worth $1,417,000. Essex Savings Bank lifted its stake in iShares Nasdaq Biotechnology ETF by 114.1% in the second quarter. Essex Savings Bank now owns 4,503 shares of the financial services provider’s stock worth $491,000 after purchasing an additional 2,400 shares during the last quarter. Finally, Bray Capital Advisors lifted its stake in iShares Nasdaq Biotechnology ETF by 11.2% in the second quarter. Bray Capital Advisors now owns 20,427 shares of the financial services provider’s stock worth $2,229,000 after purchasing an additional 2,051 shares during the last quarter. Institutional investors own 78.94% of the company’s stock.
Separately, ValuEngine downgraded shares of iShares Nasdaq Biotechnology ETF from a “buy” rating to a “hold” rating in a research note on Tuesday, October 22nd.
iShares Nasdaq Biotechnology ETF stock traded up $2.51 during mid-day trading on Friday, hitting $109.85. The company’s stock had a trading volume of 2,133,600 shares, compared to its average volume of 2,072,578. iShares Nasdaq Biotechnology ETF has a 12 month low of $89.01 and a 12 month high of $116.25. The business has a 50 day moving average price of $102.75 and a 200-day moving average price of $104.53.
iShares Nasdaq Biotechnology ETF Profile
iShares Nasdaq Biotechnology ETF (the Fund), formerly iShares Nasdaq Biotechnology Index Fund, is an exchange-traded fund (ETF). The Fund seeks investment results that correspond generally to the price and yield performance of the NASDAQ Biotechnology Index (the Index). The Index contains securities of NASDAQ listed companies that are classified according to the Industry Classification Benchmark as either biotechnology or pharmaceuticals, which also meet other eligibility criteria determined by NASDAQ.
Recommended Story: Cash Flow Analysis in Stock Selection
Want to see what other hedge funds are holding IBB? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for iShares Nasdaq Biotechnology ETF (NASDAQ:IBB).